Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler

Horton Disease Clinical Trial

— VELHOR  

Official title:

Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03360162
• Other study ID #: VELHOR ( 29BRC17.0227)
• Status: Completed
• Start date: November 2, 2017
• Est. completion date: December 10, 2017

Study information

• Verified date: April 2020
• Source: University Hospital, Brest
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The use of ultrasonography in detecting giant cell arteritis ( GCA) is emerging. Currently, temporal biopsy is the gold standard to diagnose GCA but studies have shown the interest to use B mode ultrasonography. However, until now, the study of velocities in GCA have not been yet performed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: December 10, 2017
• Est. primary completion date: December 10, 2017
• Gender: All
• Age group: 55 Years and older

Eligibility

Inclusion Criteria:

• patients with suspicious giant arteritis

Exclusion Criteria:

• patients who have already been treated or diagnosed for giant arteritis

Related Conditions & MeSH terms

• Giant Cell Arteritis
• Horton Disease
• Polymyalgia Rheumatica

Locations

Country	Name	City	State
France	CHRU de Brest	Brest

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler	velocimetric temporal arterial study in giant arteritis	2 months
Secondary	evaluation of the halo sign in giant arteritis using B mode ultrasonography	presence or absence of the halo sign in giant arteritis patients	2 months